drugset / Trial / NCT01774773
A Single-dose Study in Healthy Japanese Male Adults to Evaluate Pharmacokinetics and Pharmacodynamics of E5501 5 mg Tablet (Study E5501-J081-015)
RandomizedCrossoverOpen-labelTreatment
Summary
E5501 (5 mg, 20 mg, and 40 mg) will be administered to healthy male adults in a single-center, randomized, open-label, cross-over manner. This study will consist of 2 phases including pre-randomization (before drug administration) and postrandomization (after drug administration).
Timeline
- Start
- 2013-01
- Primary completion
- 2013-07
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Avatrombopag | Small molecule | 5 mg | — |
| Subject | Avatrombopag | Small molecule | 20 mg | — |
| Subject | Avatrombopag | Small molecule | 40 mg | — |
Indications
No indication recorded.